Expression of Adhesion Molecules and von Willebrand Factor in Human Coronary Artery Endothelial Cells Incubated with Differently Modified Hemoglobin Solutions

References

• Hess JR. Review of modified hemoglobin research at Letterman: attempts to delineate the toxicity of cell-free tetrameric hemoglobin. Artif Cells Blood Substit Immobil Biotechnol 1995; 23: 277–89
   PubMed Web of Science ®Google Scholar
• Winslow RM. Blood substitutes – a moving target. Nature Med 1995; 1(11)1212–15
   PubMedGoogle Scholar
• Zuck T F, Riess JG. Current status of injectable oxygen carriers. Crit Rev Clin Lab Sci 1994; 31: 295–324
   PubMed Web of Science ®Google Scholar
• Marwick C. More than a trickle of interest in blood substitutes. JAMA 1994; 271: 895
   PubMedGoogle Scholar
• Macdonald V W, Winslow R M, Marini M A, Klinker MT. Coronary vasoconstrictor activity of purified and modified human hemoglobin. Biomater Artif Cells Artif Organs 1990; 18: 236–82
   Google Scholar
• Greenburg A G, Kim HW. Nitrosyl hemoglobin formation in-vivo after intravenous administration of a hemoglobin- based oxygen carrier in endotoxemic rats. Artif Cells Blood Substit Immobil Biotechnol 1995; 23: 271–6
   PubMed Web of Science ®Google Scholar
• Feola M, Simoni J, Tran R, Canizaro PC. Mechanism of toxicity of hemoglobin solutions. Biomater Artif Cells Artif Organs 1990; 16: 217–26
   Google Scholar
• Simoni J, Feola M, Canizaro PC. Generation of free oxygen radicals and toxicity of hemoglobin solutions. Biomater Artif Cells Artif Organs 1990; 18: 189–202
   PubMed Web of Science ®Google Scholar
• Alayash AI. Hemoglobin-based blood substitutes: potential free radical toxicity. Free Rod Biol Med 1994; 16: 137–8
   PubMedGoogle Scholar
• Chang TMS. Abstracts from the VI International Symposium on Blood Substitutes. Artif Cells Blood Substit Immobil Biotechnol 1996; 24: 295–464
   Google Scholar
• Simoni J, Simoni G, Lox C D, Feola M. Reaction of human endothelial cells to bovine hemoglobin solution and tumor necrosis factor. Artif Cells Blood Substit Immobil Biotechnol 1994; 22: 777–87
   PubMed Web of Science ®Google Scholar
• Simoni J, Simoni G, Lox C D, McGunegle D E, Feola M. Cytokines and PAF release from human monocytes and macrophages: effect of hemoglobin and contaminants. Artif Cells Blood Substit Immobil Biotechnol 1994; 22: 525–34
   PubMed Web of Science ®Google Scholar
• McFaul S J, Bowman P D, Villa V M, Gutierrez-Ibanez M J, Johnson M, Smith D. Hemoglobin stimulates mononuclear leukocytes to release interleukin-8 and tumor necrosis factor alpha. Blood 1994; 84: 3175–81
   PubMed Web of Science ®Google Scholar
• Smith D J, Winslow RM. Effects of extraerythrocytic hemoglobin and its components on mononuclear cell procoagulant activity. J Lab Clin Med 1992; 119: 176–82
   PubMed Web of Science ®Google Scholar
• Kleber E E, Lynch S R, Skikne B, Torrance J D, Bothwell T H, Charlton RW. Erythrocytes catabolism in the inflammatory peritoneal monocyte. Br J Haematol 1978; 39: 41–54
   PubMed Web of Science ®Google Scholar
• Deiss A. Iron metabolism in reticuloendothelial cells. Sem Hematol 1983; 20: 81–90
   PubMed Web of Science ®Google Scholar
• Stremmel W, Riedel H D, Niederau C, Strohmeyer G. Pathogenesis of genetic haemochromatosis. Eur J Clin Invest 1993; 23: 321–9
   PubMed Web of Science ®Google Scholar
• Balla G, Vercellotti G M, Muller-Eberhard U, Eaton J, Jacob HS. Exposure of endothelial cells to free heme potentiates damage mediated by granulocytes and toxic oxygen species. Lab Invest 1991; 64: 648–55
   PubMed Web of Science ®Google Scholar
• Balla J, Jacob H S, Balla G, Nath K, Eaton J W, Vercellotti GM. Endothelial-cell heme uptake from heme proteins: induction of sensitization and desensitization to oxidant damage. Proc Natl Acad Sci USA 1993; 90: 9285–9
   PubMed Web of Science ®Google Scholar
• Motterlini R, Foresti R, Vandegriff K, Intaglietta M, Winslow RM. Oxidative-stress response in vascular endothelial cells exposed to acellular hemoglobin solutions. Am J Physiol 1995; 269: H648–55
   PubMed Web of Science ®Google Scholar
• Benton L D, Khan M, Greco RS. Integrins, adhesion molecules and surgical research. Surg Gynecol Obstet 1993; 177: 311–27
   PubMedGoogle Scholar
• Winn R K, Sharar S R, Vedder N B, Harlan JM. Leukocyte and endothelial adhesion molecules in ischaemia/reperfusion injuries. Cell Adhesion and Human Disease, J Marsh, JA Goode. John Wiley & Sons Ltd, ChichesterEngland 1995; 63–78
   Google Scholar
• Smith CW. Transendothelial migration. Adhesion: Its Role In Inflammatory Disease, JM Harlan, DY Liu. WH Freeman, New York, NY 1992; 83–115
   Google Scholar
• Pober J S, Cotran RS. Cytokines and endothelial cell biology. Physiol Rev 1990; 70: 427–51
   PubMed Web of Science ®Google Scholar
• Meyers C L, Wertheimer S J, Schembri-King J, Parkas T, Wallace RW. Induction of ICAM-1 by TNF-alpha, IL-1-beta, and LPS in human endothelial cells after downregulation of PKC. Am J Physiol 1992; 263: C767–72
   PubMedGoogle Scholar
• Lo S K, Janakidevi K, Lai L, Malik AB. Hydrogen peroxide-induced increase in endothelial adhesiveness is dependent on ICAM-1 activation. Am J Physiol 1993; 264: L406–12
   PubMed Web of Science ®Google Scholar
• Gasic A C, McGuire G, Krater S, Farhood A I, Goldstein M A, Smith C W, Entman M L, Taylor AA. Hydrogen peroxide pretreatment of perfused canine vessels induces ICAM-1 and CD18-dependent neutrophil adherence. Circulation 1991; 84: 2154–66
   PubMed Web of Science ®Google Scholar
• McFaul S J, Bowman P D, Ibanez M G, Holt P. The effects of purified hemoglobin solutions on leukocytes and endothelial cells. Biomater Artif Cells Artif Organs 1991; 19: 436
   Google Scholar
• Feola M, Simoni J, Canizaro PC. U.S. Patent. 5 439 882, 1995, Blood Substitute
   Google Scholar
• Feola M, Simoni J, Canizaro PC. European Patent No. EP 0 507 870, 1996, Polyhemoglobin Stabilized with Purine Derivatives and Glutathione
   Google Scholar
• Simoni J, Simoni G, Feola M. Chromatographic analysis of biopolymers distribution in “poly-hemoglobin”, an intermolecularly crosslinked hemoglobin solution. Anal Chim Acta 1993; 279: 73–88
   Google Scholar
• Feola M, Simoni J, Canizaro PC. Quality control of hemoglobin solutions: I. the purity of hemoglobin before modification. Artif Organs 1991; 15: 234–278
   Google Scholar
• Simoni J, Simoni G, Feola M, Canizaro PC. Evaluation of anion-exchange liquid chromatography for purification of hemoglobin from peptides and other proteins. Anal Chim Acta 1991; 249: 169–83
   Web of Science ®Google Scholar
• Winterboum CC. Reactions of superoxide with hemoglobin. Handbook of Methods for Oxygen Radicals Research, RA Greenwald. CRC Press, Boca Raton, FL 1985; 137–41
   Google Scholar
• Yoshida Y, Kashiba K, Niki E. Free radical mediated oxidation of lipids induced by hemoglobin in aqueous dispersions. Biochim Biophys Acta 1994; 1201: 165–72
   PubMed Web of Science ®Google Scholar
• Sen C K, Roy S, Packer L. Involvement of intracellular Ca2+ in oxidant-induced NF-kappa B activation. FEBS Lett 1996; 385: 58–62
   PubMed Web of Science ®Google Scholar
• Pahl H L, Baeuerle PA. Oxygen and the control of gene expression. BioEssays 1994; 16: 497–502
   PubMed Web of Science ®Google Scholar
• Anadalibi A, Liao F, Imes S, Fogelman A M, Lusis AJ. Oxidized lipoproteins influence gene expression by causing oxidative stress and activating the transcription factor NF-kappa B. Biochem Soc Trans 1993; 21: 651–655
   PubMedGoogle Scholar
• Schreck R, Albermann K, Baeuerle PA. Nuclear factor kappa B: an oxidative stress responsive transcription factor of eukaryotic cells. Free Rad Res Commun 1992; 17: 221–37
   PubMed Web of Science ®Google Scholar
• Kwak E L, Larochelle D A, Beaumont C, Torti FM. Role of NF-kappa B in the regulation of ferritin H by tumor necrosis factor-alpha. J Biol Chem 1995; 270: 15285–93
   PubMed Web of Science ®Google Scholar
• Lavrovsky Y, Schwartzman M L, Levere R D, Kappas A, Abraham NG. Identification of binding sites for transcription factors NF-kappa B and AP-2 in the promoter region of the human oxygenase 1 gene. Proc Natl Acad Sci USA 1994; 91: 5987–91
   PubMed Web of Science ®Google Scholar
• Kutty R K, Daniel R F, Ryan D E, Levin W, Maines MD. Rat liver cytochrome P-450b, P-420b, and P-420c are degraded to biliverdin by heme oxygenase. Arch Biochem Biophys 1988; 260: 638–44
   PubMed Web of Science ®Google Scholar
• White K A, Marietta MA. Nitric oxide synthase is a cytochrome P-450 type hemoprotein. Biochemistry 1992; 31: 6627–31
   PubMed Web of Science ®Google Scholar
• Crow J P, Spruell C, Chen J, Gum C, Ischiropoulos H, Tsai M, Smith C D, Radi R, Koppenol W H, Beckman JS. On the pH-dependent yield of hydroxyl radical products from peroxynitrite. Free Rod Biol Med 1994; 16: 331–8
   PubMed Web of Science ®Google Scholar
• Volk T, Loannidis I, Hensel M, DeGroot H, Kox WJ. Endothelial damage induced by nitric oxide: synergism with reactive oxygen species. Biochem Biophys Res Commun 1995; 213: 196–203
   PubMed Web of Science ®Google Scholar
• Jia L, Bonaventura C, Bonaventura J, Stamler JS. S-nitrosohaemoglobin: a dynamic activity of blood involved in vascular control. Nature 1996; 380: 221–6
   PubMed Web of Science ®Google Scholar
• Naseem S A, Kontos M C, Rao P S, Jesse R L, Hess M L, Kukreja RC. Sustained inhibition of nitric oxide by NG-nitro-L-arginine improves myocardial function following ischemia/reperfusion in isolated perfused rat heart. J Mol Cell Cardiol 1995; 27: 419–26
   PubMedGoogle Scholar
• Edwing J F, Raju V S, Maines MD. Induction of heart heme oxygenase-1 (HSP32) by hyperthermia: possible role in stress-mediated elevation of cyclic 3′,5′-guanosine monophosphate. J Pharmacol Exp Therap 1994; 271: 408–14
   PubMedGoogle Scholar
• Morita T, Perrella M A, Lee M, Kourembanas S. Smooth muscle cell-derived carbon monoxide is a regulator of vascular cGMP. Proc Natl Acad Sci USA 1995; 92: 1475–9
   PubMed Web of Science ®Google Scholar
• Johnson R A, Lavesa M, Askari B, Abraham N G, Nasjletti A. A heme oxygenase product, presumably carbon monoxide, mediates a vasodepressor function in rats. Hypertension 1995; 25: 166–9
   PubMedGoogle Scholar
• Grimm S, Baeuerle PA. The inducible transcription factor NF-kappa B: structure-function relationship of its protein subunits. Biochem J 1993; 290: 297–308
   PubMed Web of Science ®Google Scholar
• Collins T. Endothelial nuclear factor-kappa B and the initiation of the artheriosclerotic lesion. Lab Invest 1993; 68: 499–508
   PubMed Web of Science ®Google Scholar
• Osbom L, Lobb R. Direct-expression cloning of endothelial adhesion molecules. Vascular Endothelium. Interactions with Circulating Cells, JL Gordon. Elsevier Science Publisher B.V., Amsterdam, London, New York, Tokyo 1991; 45–58
   Google Scholar
• Ewenstein B M, Jacobson B C, Brich KA. Regulated secretion in vascular endothelium. Cell-Cell Interactions in the Release of Inflammatory Mediators, PY-K Wong, CN Sehran. Plenum Press, New York, NY 1991; 141–157
   Google Scholar
• Luscinskas F W, Lawler J. Integrins as a dynamic regulator of vascular function. FASEB J 1994; 8: 929–938
   PubMed Web of Science ®Google Scholar
• Simoni J, Simoni G, Lox C D, Prien S D, Shires GT. Modified Hb solution, with low prooxidant potential and desired pharmacological and anti-inflammatory properties, does not activate the transcription factor NF-kappa B in human vascular endothelial cells. Artif Cells Blood Substit Immobil Biotechnol 1996; 24: 429
   Google Scholar
• Zang H, Weir B KA, Macdonald L, Marton L S, Solenski N J, Kwan A-L, Lee KS. Mechanism of [Ca++]i elevation induced by erythrocyte components in endothelial cells. J Phramacol Exp Ther 1996; 277: 1501–1509
   PubMedGoogle Scholar
• Feola M, Simoni J, Angelillo R, Luhruma Z, Kabakele M, Manzobi M, Kaluila M. Clinical trial of a hemoglobin based blood substitute in patients with sickle cell anemia. Surg Gynecol Obstet 1992; 174: 379–86
   PubMedGoogle Scholar
• Simoni J, Simoni G, Newman G, Feola M. An improved blood substitute: in vivo evaluation of its hemodynamic effects. ASAIO Journal 1996; 42: M773–M782
   PubMedGoogle Scholar
• Daval J L, Nehling A, Nicolas F. Physiological and phamacological properties of adenosine: therapeutic implications. Life Sci 1991; 49: 1435–53
   PubMedGoogle Scholar
• Cronstein BN. Adenosine, an endogenous anti-inflammatory agent. J Appl Physiol 1994; 76: 5–13
   PubMed Web of Science ®Google Scholar
• Maggirwar S B, Dhanraj D N, Somani S M, Ramkumar V. Adenosine acts as an endogenous activator of the cellular antioxidant defense system. Biochem Biophys Res Commun 1994; 201: 508–15
   PubMed Web of Science ®Google Scholar
• Bouma M G, Stad R K, Van der Wildenberg F AJM., Buurman WA. Differential regulatory effects of adenosine on cytokine release by activated human monocytes. J Immunol 1994; 153: 4159–68
   PubMed Web of Science ®Google Scholar
• Bouma M G, Van der Wildenberg F AJM., Buurman WA. Adenosine inhibits cytokine release and expression of adhesion molecules by activated human endothelial cells. Am J Physiol 1996; 270: C522–9
   PubMedGoogle Scholar
• Adkins W K, Barnard J W, May S, Siebert A F, Haynes J, Taylor AE. Compounds that increase cAMP prevent ischemia-reperfusion pulmonary capilary injury. J Appl Physiol 1992; 72: 492–7
   PubMed Web of Science ®Google Scholar
• Morandini R, Ghanem G, Portier-Lemarie A, Robaye B, Renaud A, Boeynaems JM. Action of cAMP on expression and release of adhesion molecules in human endothelial cells. Am J Physiol 1996; 270: H807–H816
   PubMedGoogle Scholar
• Ghersa P, Van Huijsduijnen R H, Whelan J, Cambert Y, Pescini R, DeLamarter JF. Inhibition of E-selectin gene transcription through a cAMP-dependem protein kinase pathway. J Biol Chem 1994; 269: 29129–37
   PubMedGoogle Scholar
• Lincoln T M, Comwell T L, Taylor AE. cAMP-dependent protein kinase mediated the reduction of Ca2+ by cAMP in vascular smooth muscle cells. Am J Physiol 1990; 258: C300–407
   Google Scholar
• Grisham M B, Hemandez L A, Granger DN. Adenosine inhibits ischemia-reperfusion-induced leukocyte adherence and extravasation. Am J Physiol 1989; 257: H1334–9
   PubMedGoogle Scholar